Insight Molecular Diagnostics Inc. Total Liabilities and Equity
Insight Molecular Diagnostics Inc. (IMDX) had Total Liabilities and Equity of $29.44 million as of 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Balance Sheet
us-gaap:LiabilitiesAndStockholdersEquity · last filed 2026-08-10
- 2026-06-30: Liabilities and Equity $29.44M.
- 2026-03-31: Liabilities and Equity $40.43M.
- 2025-12-31: Liabilities and Equity $25.76M.
- 2025-09-30: Liabilities and Equity $43.94M.
| Period end | Liabilities and Equity |
|---|---|
| 2026-06-30 | $29.44M 10-Q · filed 2026-08-10 |
| 2026-03-31 | $40.43M 10-Q · filed 2026-05-13 |
| 2025-12-31 | $25.76M 10-Q · filed 2026-08-10 |
| 2025-09-30 | $43.94M 10-Q · filed 2025-11-10 |
| 2025-06-30 | $50.52M 10-Q · filed 2025-08-11 |
| 2025-03-31 | $60.36M 10-Q · filed 2025-05-12 |
| 2024-12-31 | $35.08M 10-K · filed 2026-03-26 |
| 2024-09-30 | $70.22M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $74.72M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $70.97M 10-Q · filed 2024-05-15 |
| 2023-12-31 | $74.89M 10-K · filed 2025-03-24 |
| 2023-09-30 | $81.59M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $87.54M 10-Q · filed 2023-08-10 |
| 2023-03-31 | $82.80M 10-Q · filed 2023-05-15 |
| 2022-12-31 | $100.09M 10-K · filed 2024-04-16 |
| 2022-09-30 | $157.34M 10-Q · filed 2022-11-10 |
| 2022-06-30 | $171.05M 10-Q · filed 2022-08-12 |
| 2022-03-31 | $146.27M 10-Q · filed 2022-05-12 |
| 2021-12-31 | $159.56M 10-K · filed 2023-04-12 |
| 2021-09-30 | $168.34M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $177.38M 10-Q · filed 2021-08-11 |
| 2021-03-31 | $129.31M 10-Q · filed 2021-05-17 |
| 2020-12-31 | $55.42M 10-K · filed 2022-03-11 |
| 2020-09-30 | $57.78M 10-Q · filed 2020-11-12 |
| 2020-06-30 | $63.45M 10-Q · filed 2020-07-29 |
| 2020-03-31 | $59.50M 10-Q · filed 2020-05-12 |
| 2019-12-31 | $39.86M 10-K · filed 2021-03-19 |
| 2019-09-30 | $32.77M 10-Q · filed 2019-11-14 |
| 2019-06-30 | $37.67M 10-Q · filed 2019-08-14 |
| 2019-03-31 | $41.68M 10-Q · filed 2019-05-14 |
| 2018-12-31 | $9.52M 10-K · filed 2020-03-26 |
| 2018-09-30 | $12.90M 10-Q · filed 2018-11-13 |
| 2018-06-30 | $12.20M 10-Q · filed 2018-08-14 |
| 2018-03-31 | $15.58M 10-Q · filed 2018-05-15 |
| 2017-12-31 | $10.22M 10-K · filed 2019-04-01 |
| 2017-09-30 | $14.25M 10-Q · filed 2017-11-14 |
| 2017-06-30 | $12.14M 10-Q · filed 2017-08-14 |
| 2017-03-31 | $15.17M 10-Q · filed 2017-04-28 |
| 2016-12-31 | $14.45M 10-K · filed 2018-04-02 |
| 2016-09-30 | $16.86M 10-Q · filed 2016-11-10 |
| 2016-06-30 | $7.42M 10-Q · filed 2016-08-11 |
| 2016-03-31 | $9.65M 10-Q · filed 2016-05-16 |
| 2015-12-31 | $12.73M 10-K · filed 2017-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |